Current View
Click here to download the PDF file.

Of the 720 patients diagnosed with hypertrophic cardiomyopathy(HCM), a relatively common genetic heart disease responsible for mortality and morbidity at all ages, an estimated 70% don’t have sufficient personal resources for life-saving therapy or operation that would improve longevity, shows the analysis of data from past three years compiled by the hypertrophic cardiomyopathy centre, Amrita Institute of Medical Sciences.

207
PROGRAMS
OFFERED
6
AMRITA
CAMPUSES
15
CONSTITUENT
SCHOOLS
A
GRADE BY
NAAC, MHRD
8th
RANK(INDIA):
NIRF 2018
150+
INTERNATIONAL
PARTNERS